PHARMAALLIANCE A MULTIDISCIPLINARY CONSORTIUM - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
90031259
Word Mark
PHARMAALLIANCE A MULTIDISCIPLINARY CONSORTIUM
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2021-04-26
Filing Date
2020-07-01
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
010104 - A single star with six points.
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
EVANKO, PATRICIA MALES
Statements
Description of Mark
The mark consists of an asterisk to the left of words PharmaAlliance, where Pharma is in a first font and Alliance is in a second font and PharmaAlliance is above the words A Multidisciplinary Consortium.
Goods and Services
Services for Pharmaceutical Research and Pathogen Detection Research
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-08-06
Primary Code
042
Correspondences
Name
BRIAN P. SULLIVAN
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2020-07-04 | NEW APPLICATION ENTERED IN TRAM |
2020-08-06 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-08-07 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2020-10-06 | ASSIGNED TO EXAMINER |
2020-10-13 | NON-FINAL ACTION WRITTEN |
2020-10-13 | NON-FINAL ACTION E-MAILED |
2020-10-13 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-04-26 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2021-04-26 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |